1/33
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Hospital Acquired Infection (HAI) or Nosocomial Infection
an infection acquired in hospital that was not present or incubating at admission
Why do infections occur in hospitals?
Many vulnerable, sick people are treated in close surroundings so spread easily
Common procedures increase the risk of infection, eg. catheterisation, surgery, immuno-suppressive drugs, antibiotics
Risk Factors for Nosocomial Infection
Health Status
Advanced age
Malnutrition
Alcoholism/smoking
Diabetes
Invasive Procedures
Endotracheal intubation
Bladder catheter
Intravenous catheter
Treatment
Immunosuppression
Operative procedures
Feeding via a drip
Length of stay
Entry of Organisms in a Nosocomial Infection
Colonisation of GI tract
Breech of barriers – skin
Ingestion
Inhalation
Environmental contact
Sources of Hospital Acquired Infections
Contaminated Hospital Environment
Patient Flora
Medical Personnel
Invasive Devices (Catheters, ET tubes, etc.)
Majority of HAI are
Bloodstream infections (BSIs) including IV catheters
Urinary Tract Infections (UTIs) or Catheter Associated UTIs (CAUTIS)
Surgical Site Infections (SSIs)
Pneumonia including Ventilator Associated Pneumonia (VAP)
Gastroenteritis including C. diff
Bad Bugs
problematic pathogens that “eskape” the activity of antibiotics
ESKAPE
E nterococcus faecium / VRE
S taphylococcus aureus / MRSA
K lebsiella pneumoniae
A cinetobacter baumannii
P seudomonas aeruginosa
E nterobacteriaceae / E. coli
What is inadequate antibiotic therapy associated with?
poor outcome and emergence of bacterial resistance
Antibiotics process
Appropriate and early treatment improves chance of success.
However, empirical use is often necessary as lab results take up to 48 hours
So initial therapy often involves a broad-spectrum drug. These induce resistance rapidly!
When results come in then specifically tailor treatment to pathogen and resistance profile.
Consequences of Antimicrobial Resistance
Mortality: resistant infections = more fatal
Morbidity: prolonged illness, greater chance of resistant organism spread
Cost: increase cost of care & newer/more expensive drugs
Limited Solutions: few new drugs being made
MRSA
Methicillin-Resistant Staphylococcus Aureus
Preventing MRSA
Screening – identify carriers; nasal swabs; staff! Care when colonised people sent back into the community – build up – readmitted and overwhelms.
Hand washing – scrupulous hygiene; laundry; instruments; equipment.
Isolation – exclusion until cleared; contact isolation in hospitals.
Restricting antibiotic usage – some antibiotics are associated with increased risk of colonisation eg. quinolones.
Decolonisation – remove carriage.
Agricultural practice – prevent or limit use in farming
Antibiotic Associated Colitis (AAC)/Pseudomembranous Colitis
severe condition of the colon caused by Clostridioides difficile
Results in local tissue inflammation as a complication of antibiotic therapy
Risk Factors for AAC
Existing illness
Antibiotic usage
Elderly age
Recent surgery
History of AAC
Clostridioides
Large
Gram positive rods
Anaerobes
Spores survive exposure to air
What two toxins does C. Diff release into the colon?
Enterotoxin (toxin A)
Cytotoxin (toxin B)
C. Diff Enterotoxin
induces inflammatory response
Hypersecretion of fluid
haemorrhagic necrosis
C. Diff Cytotoxin
causes actin to depolymerise
destruction of cellular cytoskeleton
When does C. Diff reach cytotoxic levels?
when it is the predominant organism
What happens to the lining of the colon during a C. Diff Infection
Denudation
Haemorrhagic
AAC Pathology
small white/yellow plaques that, with time, enlarge and develop a haemorrhagic border
epithelium become necrotic and slough off forming a pseudomembrane with inflammatory exudate
AAC Symptoms
Fever
diarrhoea
abdominal distension/pain
AAC Diagnosis
made on the basis of a history of antibiotic therapy within the past month and on the clinical symptoms
Colonoscopy revealing the classical pathology (pseudomembrane) can add weight to the diagnosis.
The faeces can be tested for the presence of the etiological agent and/or the presence of toxin A.
Transmission of C.Diff
Faecal oral route
hands of people who come into contact with infected individuals/surfaces
C. Diff Spores
produced when C. Diff bacteria encounter unfavorable conditions
Survive on clothes/surfaces for long periods
Resistant to hand sanitizer and routine cleaning
Reduction of C.Diff due to
Raised awareness due to mandatory reporting as of 2004
Reinforced infection prevention/control measures
Enhanced surveillance and screening
More prudent antibiotic use
Improved diagnostics
Better epidemiological tracking (including ribotyping)
3 Types of Antibiotic Resistance
Natural/Intrinsic
Mutational Acquired
Extrachromosomal Acquired
Natural/Intrinsic Resistance
Resistance to a drug prior to exposure
Ex: low permeability of wall/membrane to drugs
Mutational Acquired Drug Resistance
Resistance develops in response to exposure to a drug
Extrachromosomal Acquired Resistance
(Disseminated by plasmids, transposons or other DNA) - Resistance develops in response to exposure to a drug
Aquired Resistance is driven by 2 genetic processes in bacteria
Mutation and Selection (Vertical evolution)
Exchange of genes between strains and species (horizontal evolution)
Why are antibiotic resistant bacteria “selected for” in nature so rapidly?
Bacteria are small → small volumes = large numbers of bacteria → lots of chances for mutation
Mutation
Any heritable change in the nucleotide sequence of DNA
Substitutions
Insertions
Deletions